Universe Pharmaceuticals (UPC) Change in Accured Expenses (2020 - 2025)
Historic Change in Accured Expenses for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $262.6 million.
- Universe Pharmaceuticals' Change in Accured Expenses fell 9992.56% to $262.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.6 million, marking a year-over-year decrease of 9992.56%. This contributed to the annual value of $262.6 million for FY2025, which is 9992.56% down from last year.
- As of Q3 2025, Universe Pharmaceuticals' Change in Accured Expenses stood at $262.6 million, which was down 9992.56% from $352.9 billion recorded in Q3 2024.
- In the past 5 years, Universe Pharmaceuticals' Change in Accured Expenses ranged from a high of $352.9 billion in Q3 2024 and a low of $444319.0 during Q3 2021
- Moreover, its 5-year median value for Change in Accured Expenses was $2.6 million (2022), whereas its average is $44.1 billion.
- Per our database at Business Quant, Universe Pharmaceuticals' Change in Accured Expenses plummeted by 9999.99% in 2021 and then skyrocketed by 1301200737.33% in 2024.
- Universe Pharmaceuticals' Change in Accured Expenses (Quarter) stood at $444319.0 in 2021, then soared by 471.52% to $2.5 million in 2022, then increased by 6.79% to $2.7 million in 2023, then soared by 13012007.37% to $352.9 billion in 2024, then crashed by 99.93% to $262.6 million in 2025.
- Its Change in Accured Expenses stands at $262.6 million for Q3 2025, versus $352.9 billion for Q3 2024 and $2.7 million for Q1 2024.